Growth Metrics

Jazz Pharmaceuticals (JAZZ) Total Debt Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5.94%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 103.99%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.07%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn -0.24%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.24%
Dec 31, 2025 -12.28%
Sep 30, 2025 -12.28%
Jun 30, 2025 -6.00%
Mar 31, 2025 -6.01%
Dec 31, 2024 6.93%
Sep 30, 2024 6.94%
Jun 30, 2024 -0.19%
Mar 31, 2024 -0.18%
Dec 31, 2023 -0.20%
Sep 30, 2023 -0.20%
Jun 30, 2023 -5.04%
Mar 31, 2023 -5.03%
Dec 31, 2022 -5.38%
Sep 30, 2022 -8.78%
Jun 30, 2022 -10.64%
Mar 31, 2022 186.63%
Dec 31, 2021 188.80%
Sep 30, 2021 200.73%
Jun 30, 2021 220.39%
Mar 31, 2021 30.51%
Dec 31, 2020 30.34%
Sep 30, 2020 30.14%
Jun 30, 2020 31.34%
Mar 31, 2020 0.73%
Dec 31, 2019 0.68%
Sep 30, 2019 0.64%
Jun 30, 2019 0.60%
Mar 31, 2019 1.04%
Dec 31, 2018 0.97%
Sep 30, 2018 0.89%
Jun 30, 2018 -4.80%
Mar 31, 2018 -15.65%
Dec 31, 2017 -22.10%
Sep 30, 2017 -27.64%
Jun 30, 2017 41.79%
Mar 31, 2017 58.42%
Dec 31, 2016 70.78%
Sep 30, 2016 69.30%
Jun 30, 2016 -13.71%
Mar 31, 2016 -11.91%
Dec 31, 2015 -11.47%
Sep 30, 2015 -3.81%
Jun 30, 2015 14.21%
Mar 31, 2015 12.13%
Dec 31, 2014 144.09%
Sep 30, 2014 143.28%
Jun 30, 2014 116.63%
Mar 31, 2014 165.67%
Dec 31, 2013 20.41%
Sep 30, 2013 19.20%
Jun 30, 2013 18.03%
Jun 30, 2012 11,598.50%